The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.

Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.

A company spun out of Jennifer Doudna's Nobel Prize-winning lab at UC Berkeley 15 years ago is looking to sell off its assets ...

Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Despite Nobel Prize origins, Caribou has succumbed to a sector shifting its focus to in vivo CAR-T approaches.

The World Health Organization released its first guidelines addressing the sharp rise in obesity among children and adolescents ...

Caribou Biosciences, the off-the-shelf cell therapy outfit that spun out of Nobel Laureate Jennifer Doudna’s lab in 2011, is ...

A patient in Germany has been successfully treated with a drug based on CRISPR gene-editing technology for the first time ...

The Nobel Prize in Chemistry includes famous winners such as Marie Curie and Otto Hahn.

This year's Nobel Prize in Chemistry has been awarded to French researcher Henri Kagan and Japanese researcher Kenso Soai for ...

Henri Kagan and Kenso Soai are receiving this year's Nobel Prize for their work on the origin of chemical asymmetry. The ...